Injectable storage guidelines should follow the exact product, formulation, and package received by the clinic. Aesthetic injectables do not share one universal temperature range, refrigeration rule, or post-opening timeline. Dermal fillers may require controlled room-temperature storage, while some neuromodulators have different conditions before and after reconstitution.
For med spas, the goal is to receive each shipment correctly, place it in the right environment, preserve package integrity, document traceability, and keep questionable inventory out of use until its status is resolved. The current US prescribing information or manufacturer instructions for use should remain the controlling source for every product-specific decision.
Injectable Storage Guidelines by Product Type
The dermal filler storage temperature varies by formulation. Maintain a storage matrix using the complete label name rather than a shortened brand name.
| Product and formulation | Unopened storage | Important handling controls |
| Xeomin single-dose vial | At or below 25°C; refrigeration is not required | After reconstitution, refrigerate at 2°C to 8°C for up to 24 hours. Discard unused portions. |
| Radiesse (+) | Controlled room temperature from 15°C to 32°C | Do not use after expiration. Used and partially used syringes require appropriate disposal. |
| Belotero Balance (+) | Room temperature up to 25°C | Keep away from heat. Do not freeze. Discard unused or partially used syringes. |
| Revanesse Versa (+) | 2°C to 25°C | Protect from direct sunlight and freezing. Confirm the seal is intact. Single use only. |
Current FDA labeling states that unopened Xeomin may be stored at or below 25°C without refrigeration. Reconstituted Xeomin may be refrigerated at 2°C to 8°C for up to 24 hours, and its vials are single-dose.
Radiesse (+) instructions specify 15°C to 32°C. Belotero Balance (+) is stored up to 25°C, away from heat, and must not be frozen. Revanesse Versa (+) is stored between 2°C and 25°C with protection from direct sunlight and freezing.
How to Store and Handle Aesthetic Products
1. Inspect Every Shipment Before Storage
Match the delivery against the purchase record. Confirm the complete product name, formulation, vial strength or syringe volume, quantity, lot number, expiration date, supplier, and package condition.
Inspect the shipping carton, individual box, tamper seal, blister pack, vial, syringe, and needle packaging. Look for crushing, moisture, leakage, broken seals, cloudiness, separation, or other visible irregularities.
Belotero Balance (+) should not be used when the package is opened or damaged, and the gel should remain clear and colorless. Revanesse Versa (+) instructions also require confirmation that the box seal is intact and sterility has not been compromised.
A shipment should not enter active inventory when the product identity, package integrity, expiration status, or storage history cannot be confirmed.
2. Move Products to the Correct Storage Area
After inspection, move each product directly to the location listed in the clinic’s storage matrix. Do not leave shipments in reception areas, vehicles, treatment rooms, or unpacking stations longer than necessary.
Keep room-temperature products away from windows, direct sunlight, heating equipment, exterior walls, freezing air vents, and areas with wide temperature swings.
A refrigerator may fall outside labeled conditions for products intended for controlled room temperature. The official label should determine whether refrigeration is required, permitted, or unnecessary.
Unopened Xeomin, for example, does not require refrigeration. Radiesse (+), Belotero Balance (+), and Revanesse Versa (+) also use different controlled-temperature ranges rather than one standard refrigerator setting.
3. Monitor Refrigerated and Room-Temperature Areas
Monitor every location used for injectable inventory. Use a calibrated digital thermometer or data logger capable of recording minimum and maximum temperatures. Position the sensor where products are stored, not beside a refrigerator door or directly against a cooling vent.
For refrigerated products, avoid overcrowding because blocked airflow can create uneven temperatures. Keep products in their original cartons when the packaging provides identification or protection. Separate injectables from food, beverages, specimens, and unrelated supplies.
For room-temperature products, define the operating range using the narrowest labeled requirement among products in that area. If one filler has a lower upper limit, the room must stay within that tighter range or the product should be moved.
The clinic procedure should also define:
- How often staff review temperature readings
- Who responds to an alarm or out-of-range result
- Where records are stored
- What happens during a power failure
- Which products require immediate quarantine
4. Preserve Identity, Packaging, and Traceability
Keep each product in its original labeled package until preparation. Do not remove syringes or vials from cartons only to save space. The carton helps verify formulation, lot number, expiration date, and storage instructions.
Use first-expiring, first-out inventory rotation. Products approaching expiration should move to the front, but expiration order should never override concerns about damaged packaging or uncertain storage history.
The receiving record should include:
- Date and time received
- Exact product and formulation
- Quantity
- Lot number
- Expiration date
- Assigned storage location
- Package condition
- Receiving staff member
- Release or quarantine status
These records help the clinic respond to recalls, reconcile inventory, investigate handling concerns, and identify which patients received a specific lot.
5. Follow Single-Use and Post-Reconstitution Limits
Handling rules change once a vial is reconstituted or a package is opened. Do not apply one reuse policy across fillers and neuromodulators.
Xeomin is supplied in single-dose vials. After reconstitution, it may be refrigerated at 2°C to 8°C for up to 24 hours, and unused portions should be discarded.
Belotero Balance (+) is single use; its instructions direct users to discard unused product and partially used syringes. Revanesse Versa (+) is also single use. Radiesse packaging is intended for single-patient use, and used or partially used syringes should be handled as potential biohazards under facility procedures and applicable requirements.
These limits should be built into the clinic’s injectable handling best practices and staff training.
6. Quarantine Products With an Uncertain History
Quarantine means physically separating a product and marking it unavailable while a concern is reviewed.
Quarantine a product when:
- A temperature excursion is known or suspected
- Packaging is wet, crushed, leaking, opened, or damaged
- A tamper seal is broken
- The lot number or expiration date is missing
- The shipment does not match the order
- Product appearance is abnormal
- Storage instructions cannot be confirmed
- Authenticity or sourcing remains uncertain
Record the product, lot, quantity, date, reason, and assigned reviewer. Do not return it to active inventory until the disposition is documented.
Questionable inventory should remain in a marked Do Not Use area that is physically separate from released stock.
7. Respond to Temperature Excursions Systematically
A temperature excursion is any known or suspected period outside the product’s labeled range.
Remove the affected product from active inventory and label it Do Not Use. Keep it under controlled conditions during review. Record the temperature, estimated duration, lot number, quantity, storage location, and how the excursion was discovered.
Preserve:
- Photographs
- Temperature logs
- Shipment indicators
- Carrier records
- Original packaging
- Alarm notifications
- Staff statements when relevant
Contact the manufacturer or professional supplier for product-specific guidance. Do not infer stability from appearance alone.
Document whether the product was released, returned, replaced, or discarded. Identify the cause, such as power loss, refrigerator failure, delayed unpacking, or incorrect storage assignment, and revise the process when necessary.
8. Maintain a Practical Compliance File
A med spa compliance storage file should be concise but sufficient to reconstruct what happened to a product.
Keep:
- Current official labels and instructions for use
- Product-specific storage matrix
- Receiving and temperature logs
- Lot and expiration records
- Quarantine and excursion reports
- Manufacturer or supplier responses
- Return and disposal records
- Staff training documentation
- Equipment service or calibration records
- SOP review dates and recall procedures
These records support traceability and accountability. They do not guarantee legal compliance, successful inspections, or product performance.
Common Storage and Handling Mistakes
The most common failures are preventable:
- Applying one temperature range to every injectable
- Refrigerating products without checking the label
- Using shortened names in the storage matrix
- Leaving deliveries unpacked in uncontrolled areas
- Recording an excursion without documenting the outcome
- Keeping quarantined products beside released inventory
- Reusing single-use syringes or saving partial filler
- Relying on outdated labels or reseller summaries
Each error creates uncertainty about product identity, stability, sterility, or release status and weakens aesthetic product safety.
Final Thoughts
Effective injectable storage guidelines create one repeatable system for receiving, storing, monitoring, documenting, quarantining, and disposing of aesthetic injectables. The process must remain product-specific because temperature ranges, package restrictions, and post-reconstitution limits differ.
Verify the complete formulation, follow the current official label, assign responsibility for each step, and keep unresolved inventory outside active use. For products sourced through DeWitt Pharma, use the documentation for the exact formulation and request clarification before using any shipment with an uncertain storage or handling history.
Frequently Asked Questions
What are injectable storage guidelines?
Injectable storage guidelines are product-specific rules for temperature, packaging, expiration, traceability, quarantine, and handling. Clinics should use the current official instructions for the exact product and formulation rather than one general policy for all injectables.
Do all aesthetic injectables require refrigeration?
No. Some aesthetic injectables require refrigeration, while others are labeled for controlled room-temperature storage. Staff should verify whether refrigeration is required, permitted, or unnecessary before assigning a storage location.
What is the correct dermal filler storage temperature?
The correct dermal filler storage temperature depends on the brand and formulation. Different fillers may have different upper limits, freezing restrictions, and light-protection requirements, even when they belong to the same product category.
Can dermal fillers be stored in a medical refrigerator?
Do not refrigerate dermal fillers automatically. Refrigeration may fall outside the labeled conditions for products intended for room-temperature storage, so the exact instructions for use should control the decision.
What should staff do if an injectable shipment arrives warm?
Keep the shipment outside active inventory and document the package condition, known temperature information, delivery time, lot number, and expiration date. Contact the manufacturer or professional supplier for product-specific guidance before releasing the product.
What is a temperature excursion?
A temperature excursion is a known or suspected period outside the product’s labeled storage range. The affected inventory should be quarantined until a designated reviewer documents whether it can be released, returned, replaced, or discarded.
Can a product be used if it looks normal after a temperature excursion?
Visual appearance alone cannot confirm that labeled storage conditions were maintained. The clinic should obtain product-specific guidance and document the final disposition before use.
Can a partially used dermal filler syringe be stored for later use?
Do not assume a partially used filler syringe can be saved. Many aesthetic fillers are labeled for single-patient or single-use handling, so staff should follow the product’s packaging, reuse, and disposal instructions.
How should reconstituted neuromodulators be stored?
Post-reconstitution storage depends on the specific neuromodulator. The clinic should document the reconstitution time, required temperature, labeled use period, and discard deadline immediately after preparation.
What should be included in a med spa compliance storage log?
A med spa compliance storage log should record the product name, formulation, lot number, expiration date, storage location, temperature readings, receiving staff member, and release or quarantine status. Excursions should also include the response, reviewer, and final disposition.
When should injectable inventory be quarantined?
Quarantine inventory when packaging is damaged, seals are broken, storage history is uncertain, temperature limits may have been exceeded, or the product does not match the order. Mark it clearly as Do Not Use and keep it physically separate from released stock.
How often should injectable storage procedures be reviewed?
Review procedures when adding a product, changing formulations, receiving updated labeling, replacing monitoring equipment, or investigating an excursion. A scheduled periodic review should also confirm that staff responsibilities, product records, and storage ranges remain current.
